Last edition
News about "DifGen ANDA approval"
US FDA Approves DifGen's Epinephrine Injection, 1 mg/mL
DifGen gets US FDA approval for Epinephrine Injection USP 1 mg/mL, its second generic to Adrenalin, expanding its injectable portfolio.
DifGen ANDA Approval | 18/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members